Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Getting More Done With Less Blood.

2.

The Benefits of Exercise for Substance Use Disorders.

3.

Why are so many young adults getting cancer?

4.

Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers

5.

Early breast cancer detection may be possible with a wearable ultrasound scanner.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot